New Zealand markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
180.35+1.50 (+0.84%)
At close: 04:00PM EDT
180.06 -0.29 (-0.16%)
After hours: 06:07PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 26.53B
Enterprise value 27.71B
Trailing P/E 29.86
Forward P/E 22.62
PEG ratio (5-yr expected) 1.70
Price/sales (ttm)5.91
Price/book (mrq)5.92
Enterprise value/revenue 6.15
Enterprise value/EBITDA 19.38

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-20.41%
S&P500 52-week change 323.06%
52-week high 3243.52
52-week low 3132.24
50-day moving average 3185.91
200-day moving average 3172.84

Share statistics

Avg vol (3-month) 31.06M
Avg vol (10-day) 31.13M
Shares outstanding 5147.09M
Implied shares outstanding 6147.09M
Float 8145.65M
% held by insiders 10.82%
% held by institutions 157.22%
Shares short (28 Mar 2024) 47.89M
Short ratio (28 Mar 2024) 46.91
Short % of float (28 Mar 2024) 46.12%
Short % of shares outstanding (28 Mar 2024) 45.37%
Shares short (prior month 29 Feb 2024) 46.76M

Dividends & splits

Forward annual dividend rate 41.92
Forward annual dividend yield 41.06%
Trailing annual dividend rate 31.84
Trailing annual dividend yield 31.03%
5-year average dividend yield 40.87
Payout ratio 430.46%
Dividend date 314 Mar 2024
Ex-dividend date 407 Feb 2024
Last split factor 22:1
Last split date 331 Aug 2010

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 19.77%
Operating margin (ttm)29.18%

Management effectiveness

Return on assets (ttm)11.19%
Return on equity (ttm)21.66%

Income statement

Revenue (ttm)4.5B
Revenue per share (ttm)30.63
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 1.37B
Net income avi to common (ttm)890.39M
Diluted EPS (ttm)6.04
Quarterly earnings growth (yoy)-7.20%

Balance sheet

Total cash (mrq)217.86M
Total cash per share (mrq)1.48
Total debt (mrq)1.39B
Total debt/equity (mrq)31.04%
Current ratio (mrq)3.11
Book value per share (mrq)30.47

Cash flow statement

Operating cash flow (ttm)1.08B
Levered free cash flow (ttm)812.89M